Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Mercadolibre Inc (MELI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Mercadolibre Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.53 (market cap $12.58B), while Mercadolibre Inc trades at $1,886.19 (market cap $94.13B). The key difference: Mercadolibre Inc is far larger — about 7.5× Halozyme Therapeutics Inc. Common Stock's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Halozyme Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Mercadolibre Inc for 117 Days on average.
| HALO | MELI | |
|---|---|---|
Market Cap | $12.58B | $94.13B |
Volume | 2,179,278 | 273,781 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $2.36K |
52-Week Low | $61.63 | $1.55K |
Typical Hold Time | 1 Days | 117 Days |
Enterprise Value | $14.49B | $101.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MercadoLibre (MELI) trades at $1,873.57, up 0.04% on the day, with a bullish technical signal from moving averages and strong support near $1,813. The company reported $28.89B revenue in 2025, though net income margin dipped to 6.91%, and recent earnings show mixed results with a beat in Q2 2026 but misses in prior quarters. Analyst consensus is strongly positive with a $2,170 price target, and cash flow from operations surged to $12.12B in 2025, underscoring robust financial health.
Outlook remains favorable due to dominant e-commerce and fintech positioning in Latin America, with revenue projected to hit $35.2B in 2026. Risks include profit margin pressures and macroeconomic volatility in key markets like Argentina. Institutional sentiment is bullish, with 73% of analysts rating it Buy, supporting potential upside near all-time highs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →
